In vitro evaluation of the potential role of sulfite radical in morphine-associated histamine release

BMC Pharmacology

Volumn 4, Issue , 2004, Pages

  Gordon, Emma M ^a   Myers, Carolyn ^a   Blumer, Jeffrey ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; DRUG PRESERVATIVE; HISTAMINE; MORPHINE SULFATE; PROSTAGLANDIN SYNTHASE; FREE RADICAL; MORPHINE; NARCOTIC ANALGESIC AGENT; SULFITE;

ARTICLE; BRONCHOSPASM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG FORMULATION; DRUG USE; EDEMA; HEMODYNAMICS; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; MAST CELL; STATISTICAL ANALYSIS; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY;

ANALGESICS, OPIOID; FREE RADICALS; HISTAMINE RELEASE; HUMANS; INFUSIONS, INTRAVENOUS; MAST CELLS; MORPHINE; SULFITES;

EID: 12944263536     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-4-21     Document Type: Article

References (34)

1. Miller RR: Clinical effects of parenteral narcotics in hospitalized medical patients. J Clin Pharmacol 1980, 20: 65-171.
2. Bhargava HN: Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behaviour. Pharmacol Rev 1994, 46: 93-324.
3. Rosow CE, Moss J, Philbin DM, Savarese JJ: Histamine release during morphine and fentanyl anesthesia. Anesthesiology 1982, 56:93-96.
4. Fahmy NR, Sunder N, Soter NA: Role of histamine in the hemodynamic and plasma catecholamine responses to morphine. Clin Pharmacol Ther 1983, 33:615-620.
5. Philbin DM, Moss J, Akins CW, Rosow CE, Kono K, Schneider RC, VerLee TR, Savarese JJ: The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology 1981, 55:292-296.
6. Doenicke A, Moss J, Lorenz W, Hoernecke R: Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes. Clin Pharmacol Ther 1995, 58:81-89.
7. Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ: Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987, 66:723-730.
8. Oustric-Mendes AC, Huart B, Le Hoang MD, Perrin-Rosset M, Pailler FM, Darbord JC, Prognon P, Gard C, Pradeau D: Study protocol: stability of morphine injected without preservative, delivered with a disposable infusion device. J Clin Pharm Ther 1997, 22: 83-290.
9. Food and Drug Aministration: Sulfite Update. FDA Bull 1984, 14:24.
10. Food and Drug Aministration: Sulfiting agents: revocation of GRAS status for use on fruits and vegetables intended to be served or sold raw to consumers: final rule. Fed Reg 1986, 267: 81-689.
11. Mottley C, Mason RP: Sulfate anion free radical formation by the peroxidation of (Bi)sulfite and its reaction with hydroxyl radical scavengers. Arch Biochem Biophys 1988, 267:681-689.
12. Sun X, Shi X, Dalal NS: Xanthine oxidase/hydrogen peroxide generates sulfur trioxide anion radical (SO3.-) from sulfite (SO3(2-) . FEBS Lett 1992, 303:213-216.
13. Mottley C, Mason RP, Chignell CF, Sivarajah K, Eling TE: The formation of sulfur trioxide radical anion during the prostaglandin hydroperoxidase-catalyzed oxidation of bisulfite (hydrated sulfur dioxide). J Biol Chem 1982, 257:5050-5055.
14. Neta P, Huie RE: Free-radical chemistry of sulfite. Environ Health Perspect 1985, 64:209-217.
15. Kaplan D, McJilton C, Luchtel D: Bisulfite induced lipid oxidation. Arch Environ Health 1975, 30:507-509.
16. Yang SF: Destruction of tryptophan during the aerobic oxidation of sulfite ions. Environ Research 1973, 6: 95-402.
17. Hayatsu H, Miller, RC: The cleavage of DNA by the oxigen dependent reaction of bisulfite. Biochem Biophys Ressearch Commun 1972, 46:120-124.
18. Beck-Speier I, Leng, A.: Responses of human neutrophils to sulfite. J Tox Environ Health 1994, 41:285-297.
19. Zaloga GP, Marik P: Sulfite-induced propofol oxidation: a cause for radical concern. Crit Care Med 2003, 31:981-983.
20. Di Bello MG, Masini E, Ioannides C, Fomusi Ndisang J, Raspanti S, Bani Sacchi T, Mannaioni PF: Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm Res 1998, 47:122-130.
21. Masini E, Palmerani B, Gambassi F, Pistelli A, Giannella E, Occupati B, Ciuffi M, Sacchi TB, Mannaioni PF: Histamine release from rat mast cells induced by metabolic activation of polyunsaturated fatty acids into free radicals. Biochem Pharmacol 1990, 39: 79-889.
22. Masini E, Giannella E, Palmerani B, Pistelli A, Gambassi F, Mannaioni PF: Free radicals induce ischemia-reperfusion injury and histamine release in the isolated guinea pig heart. Int Arch Allergy Appl Immunol 1989, 88:132-133.
23. Mannaioni PF, Masini E: The release of histamine by free radicals. Free Radic Biol Med 1988, 5:177-197.
24. Palmerani B, Pistelli A, Gambassi F, Giannella E, Masini E, Mannaioni PF: Histamine release by free radicals during prostaglandin-H-synthetase dependent oxidation of xenobiotics. Pharmacol Res Commun 1988, 20:437-438.
25. Mannaioni PF, Giannella E, Palmerani B, Pistelli A, Gambassi F, Bani-Sacchi T, Bianchi S, Masini E: Free radicals as endogenous histamine releasers. Agents Actions 1988, 23:129-142.
26. Masini E, Lodovici M, Fantozzi R, Brunelleschi S, Conti A, Mannaioni PF: Histamine release by free radicals: paracetamol-induced histamine release from rat peritoneal mast cells after in vitro activation by monooxygenase. Agents Actions 1986, 18: 5-88.
27. Bray RJ, Beeton C, Hinton W, Seviour JA: Plasma morphine levels produced by continuous infusion in children. Anaesthesia 1986, 41:753-755.
28. Schedle A, Samorapoompichit P, Fureder W, Rausch-Fan XH, Franz A, Sperr WR, Sperr W, Slavicek R, Simak S, Klepetko W, Ellinger A, Ghannadan M, Baghestanian M, Valent P: Metal ion-induced toxic histamine release from human basophils and mast cells. J Biomed Mater Res 1998, 39:560-567.
29. Hosoda M, Yamaya M, Suzuki T, Yamada N, Kamanaka M, Sekizawa K, Butterfield JH, Watanabe T, Nishimura H, Sasaki H: Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J Immunol 2002, 169: 482-1491.
30. Watanabe Y, Todome Y, Ohkuni H, Sakurada S, Ishikawa T, Yutsudo T, Fischetti VA, Zabriskie JB: Cysteine protease activity and histamine release from the human mast cell line HMC-1 stimulated by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine protease. Infect Immun 2002, 70:3944-3947.
31. Nilsson L, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundtrom C, Nilsson K, Hellman L: . Scand J Immunol 1994, 39:489-498.
32. Baker M, Gregerson M, Martin M, Buettner G: Free radical and drug oxidation products in an intensive care unit sedative: Propofol with sulfite. Crit Care Med 2003, 31:787-792.
33. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988, 12:345-355.
34. Jensen TB, Marley PD: Development of an assay for histamine using automated high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1995, 670:199-207.